System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Nicolas Girerd is an expert in Cardiology at Centre Hospitalier Universitaire de Nancy (France). As of October 2026, ScienceLeadR ranks Nicolas Girerd in the top 1% of experts worldwide for Dyspnea, Heart Failure and Respiration Disorders. Nicolas Girerd has authored 625 publications, the most recent in 2026, and is an investigator in 65 clinical trials, 28 of them ongoing. SLR score: 3,634 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Nicolas Girerd Centre Hospitalier Universitaire de Nancy France
3 634 ScienceLeadR Reputation 3634

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Nephrology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2009 - 2026
Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 625

Citations

Citations: 17 227 1st author: 64 Last author: 151 Unique author: 7

Main journals

Eur J Heart Fail 97
Int J Cardiol 42
ESC Heart Fail 28
Clin Res Cardiol 22
Eur Heart J 20

Best Journals

Eur Heart J 9
N Engl J Med 5
Lancet 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The complexity of congestion in heart failure: a critical review of the evidence and a proposal for a multimodality approach.
PMID 42895733 — hospitalization, heart failure, heart, cardiovascular diseases, tissues		Eur Heart J Qual Care Clin Outcomes20260
Diagnostic Accuracy of NT-proBNP thresholds in Dyspneic Patients in the Emergency Department according to patients' characteristics: A Systematic Review and Meta-Analysis.
PMID 42888496 — emergencies, heart failure, aged, obesity, emergency service, hospital		Eur J Heart Fail20260
Multimodal data-driven clustering analysis of heart failure patients identifies two distinct patterns of heart failure with preserved ejection fraction: Results from the PACIFIC-PRESERVED study.
PMID 42875459 — biological science disciplines, heart failure, heart, heart failure, diastolic, cluster analysis		Nat Commun20260
"Baseline Characteristics and Utilization of Medical Therapies in Acute Hospitalized and Chronic Heart Failure Patients Enrolled in GRASP-HF: Differences Between ICARe-HF and Non-ICARe-HF Centres".
PMID 42867408 — mortality, heart failure, heart, hospital mortality, heart failure, systolic, therapeutics		Eur J Heart Fail20260
Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: A multinational electronic health record study.
PMID 42749086 — mortality, heart failure, heart, c-reactive protein, cardiology, electronic health records, risk factors, records		Int J Cardiol20260

Clinical Studies 65

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 14 Study Chair: 16 Study Director: 1

By phase:

N/A 39
Phase 3 21
Phase 2 4
Phase 4 1

By status:

Completed 23
Recruiting 22
Not yet recruiting 9
Unknown 6
Active not recruiting 4
Terminated 1

By type:

Interventional 49
Observational 16

By Monocentric/Multicentric:

monocentric 27
multicentric2to4 7
multicentric5to9 9
multicentricup10 22

Main Topics

Ongoing Clinical Trials

28 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
HF POLARIS A research study to look at how well NNC0487 0111 works compared to placebo in people with heart failure and obesity
2025-523717-29-00 — mortality, safety, heart failure, heart, heart failure, diastolic, obesity, morbidity, research		Phase 3Recruiting2026
ACetazolamide in Patients With Heart Failure to Decrease Weight and relIEVE Symptoms
NCT07737964 — acetazolamide, quality of life, mortality, heart failure, heart, tablets, signs and symptoms, diuretics, therapeutics, furosemide		Phase 3Not yet recruiting2026
EASi PROTKT A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes high blood pressure and cardiovascular disease
2025-521188-11-00 — diabetes mellitus, hypertension, safety, blood, cardiovascular diseases, blood pressure, diabetes mellitus, type 2		Phase 3Recruiting2025
ATHENA A research study looking into how ziltivekimab works compared to placebo in people with heart failure and inflammation
2023-506988-34-00 — heart failure, heart, signs and symptoms, research		Phase 3Active not recruiting2024
Remote Monitoring and Optimization of Heart Failure Therapy
NCT07622472 — monitoring, ambulatory, hospitalization, clinical decision-making, emergencies, heart failure, heart rate, heart, decision making, signs and symptoms, wearable electronic devices, monitoring, physiologic, therapeutics, respiratory rate, outpatients		N/ANot yet recruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS